Tapewire

NYSE · USD

BR

BROADRIDGE FINANCIAL SOLUTIONS, INC.

Export transactions ↓
Tapewire entity
3252
SEC CIK
0001383312
Parsed reports
1,212

Last 12 months

Inside the activity.

1 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202600
Feb 202602
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 04, 2023 Filed May 4, 2023 21:12 UTC
SCHIFELLITE ROBERTCorporate SVP
Exercise / conversionCommon Stock 12,397 $67.32 $834,566.04
Disclosure

SEC source: 0001225208-23-005427 · doc4.xml · nonDerivative · entry 1

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,008.6729

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2023 Filed May 4, 2023 20:58 UTC
Stingi Richard JohnCorporate VP and CHRO
SaleCommon Stock 750 $155.27 $116,450.40
Disclosure

SEC source: 0001225208-23-005411 · doc4.xml · nonDerivative · entry 1

Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,201.799

Read SEC document
May 04, 2023 Filed May 5, 2023 17:41 UTC
KALENKA ROBERT FCorporate Vice President
Exercise / conversionStock Option (Right to Buy) · Derivative 8,357 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-23-005450 · doc4.xml · derivative · entry 7

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,357 shares

Expires 2028-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2023 Filed May 5, 2023 17:41 UTC
KALENKA ROBERT FCorporate Vice President
Exercise / conversionStock Option (Right to Buy) · Derivative 8,932 $0.00 Strike: $98.31 $0.00
Disclosure

SEC source: 0001225208-23-005450 · doc4.xml · derivative · entry 6

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,932 shares

Expires 2029-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2023 Filed May 5, 2023 17:41 UTC
KALENKA ROBERT FCorporate Vice President
SaleCommon Stock 8,152 $152.63 $1,244,207.15
Disclosure

SEC source: 0001225208-23-005450 · doc4.xml · nonDerivative · entry 5

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,488.4097

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.235 - $153.045, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
May 04, 2023 Filed May 5, 2023 17:41 UTC
KALENKA ROBERT FCorporate Vice President
SaleCommon Stock 7,568 $152.63 $1,155,073.57
Disclosure

SEC source: 0001225208-23-005450 · doc4.xml · nonDerivative · entry 4

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,640.4097

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.235 - $153.045, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
May 04, 2023 Filed May 5, 2023 17:41 UTC
KALENKA ROBERT FCorporate Vice President
SaleCommon Stock 1,713 $152.63 $261,448.34
Disclosure

SEC source: 0001225208-23-005450 · doc4.xml · nonDerivative · entry 3

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,208.4097

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.235 - $153.045, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
May 04, 2023 Filed May 5, 2023 17:41 UTC
KALENKA ROBERT FCorporate Vice President
Exercise / conversionCommon Stock 8,357 $93.88 $784,555.16
Disclosure

SEC source: 0001225208-23-005450 · doc4.xml · nonDerivative · entry 2

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,921.4097

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2023 Filed May 5, 2023 17:41 UTC
KALENKA ROBERT FCorporate Vice President
Exercise / conversionCommon Stock 8,932 $98.31 $878,104.92
Disclosure

SEC source: 0001225208-23-005450 · doc4.xml · nonDerivative · entry 1

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,564.4097

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 06, 2023 Filed Apr 10, 2023 18:45 UTC
Carey Thomas PCorporate VP
Tax withholdingCommon Stock 2,148 $139.91 $300,520.24
Disclosure

SEC source: 0001225208-23-004785 · doc4.xml · nonDerivative · entry 1

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,754

Read SEC document
April 05, 2023 Filed Apr 5, 2023 19:03 UTC GrantCommon Stock 96 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004662 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,935

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
April 05, 2023 Filed Apr 5, 2023 15:03 UTC GrantCommon Stock 96 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004668 · doc4.xml · nonDerivative · entry 1

PERNA THOMAS J · CIK 0001209487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,895

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
April 05, 2023 Filed Apr 5, 2023 19:03 UTC GrantCommon Stock 5 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004663 · doc4.xml · nonDerivative · entry 1

FLOWERS MELVIN L · CIK 0001196490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,128

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
April 05, 2023 Filed Apr 5, 2023 19:03 UTC
keller brettDirector
GrantCommon Stock 12 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004664 · doc4.xml · nonDerivative · entry 2

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,754

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
April 05, 2023 Filed Apr 5, 2023 19:03 UTC
keller brettDirector
GrantCommon Stock 36 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004664 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,742

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
April 05, 2023 Filed Apr 5, 2023 15:02 UTC GrantCommon Stock 137 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004660 · doc4.xml · nonDerivative · entry 1

BRUN LESLIE A · CIK 0001217068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,950

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
April 05, 2023 Filed Apr 5, 2023 19:03 UTC GrantCommon Stock 3 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004666 · doc4.xml · nonDerivative · entry 1

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 837

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
April 05, 2023 Filed Apr 5, 2023 19:03 UTC
Zavery AmitDirector
GrantCommon Stock 12 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004669 · doc4.xml · nonDerivative · entry 2

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,259

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
April 05, 2023 Filed Apr 5, 2023 19:03 UTC
Zavery AmitDirector
GrantCommon Stock 13 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004669 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,247

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
April 05, 2023 Filed Apr 5, 2023 19:03 UTC GrantCommon Stock 18 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004665 · doc4.xml · nonDerivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,765.102

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
April 05, 2023 Filed Apr 5, 2023 19:03 UTC GrantCommon Stock 63 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004665 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,747.102

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
April 05, 2023 Filed Apr 5, 2023 19:03 UTC GrantCommon Stock 4 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004667 · doc4.xml · nonDerivative · entry 2

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,281

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
April 05, 2023 Filed Apr 5, 2023 19:03 UTC GrantCommon Stock 5 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004667 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,277

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
April 05, 2023 Filed Apr 5, 2023 19:03 UTC GrantCommon Stock 20 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004661 · doc4.xml · nonDerivative · entry 1

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,022

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
April 03, 2023 Filed Apr 4, 2023 20:15 UTC
keller brettDirector
GrantCommon Stock 204 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004523 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,706

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
April 03, 2023 Filed Apr 4, 2023 20:15 UTC GrantCommon Stock 204 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004524 · doc4.xml · nonDerivative · entry 1

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 834

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
April 03, 2023 Filed Apr 4, 2023 20:16 UTC
Zavery AmitDirector
GrantCommon Stock 186 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004526 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,234

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
April 03, 2023 Filed Apr 4, 2023 20:15 UTC GrantCommon Stock 204 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004525 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,272

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
April 01, 2023 Filed Apr 4, 2023 16:15 UTC
Matlin LauraVP, Deputy GC and CGO
Tax withholdingCommon Stock 466 $146.57 $68,301.62
Disclosure

SEC source: 0001225208-23-004518 · doc4.xml · nonDerivative · entry 1

Matlin Laura · CIK 0001658944 · VP, Deputy GC and CGO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,151.696

Read SEC document
April 01, 2023 Filed Apr 4, 2023 20:15 UTC Tax withholdingCommon Stock 17,499 $146.57 $2,564,828.43
Disclosure

SEC source: 0001225208-23-004516 · doc4.xml · nonDerivative · entry 1

Gokey Timothy C · CIK 0001296187 · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,014.0271

Read SEC document
April 01, 2023 Filed Apr 4, 2023 16:15 UTC
DALY RICHARD JDirector · Executive Chairman
Tax withholdingCommon Stock 742 $146.57 $108,754.94
Disclosure

SEC source: 0001225208-23-004514 · doc4.xml · nonDerivative · entry 1

DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,427.9949

Read SEC document
April 01, 2023 Filed Apr 4, 2023 20:16 UTC
Reese EdmundCorporate VP and CFO
Tax withholdingCommon Stock 547 $146.57 $80,173.79
Disclosure

SEC source: 0001225208-23-004520 · doc4.xml · nonDerivative · entry 1

Reese Edmund · CIK 0001833903 · Corporate VP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,132.45

Read SEC document
April 01, 2023 Filed Apr 4, 2023 20:15 UTC
Stingi Richard JohnCorporate VP and CHRO
Exercise / conversionFY2020 RSUs · Derivative 1,360 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004522 · doc4.xml · derivative · entry 4

Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,360 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2023 1,360 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2023 1,360 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F1 · derivative.exercise_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2023 1,360 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F1 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2023 1,360 Restricted Stock Units vested and converted into an equal number of shares of common stock.

Read SEC document
April 01, 2023 Filed Apr 4, 2023 20:15 UTC
Stingi Richard JohnCorporate VP and CHRO
Tax withholdingCommon Stock 986 $146.57 $144,518.02
Disclosure

SEC source: 0001225208-23-004522 · doc4.xml · nonDerivative · entry 3

Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,951.799

F2 · price: Represents the amount of shares withheld to cover tax liabilities upon the vesting of 1,904 performance based Restricted Stock Units that vested and converted into an equal number of shares of common stock on April 1, 2023.

Read SEC document
April 01, 2023 Filed Apr 4, 2023 20:15 UTC
Stingi Richard JohnCorporate VP and CHRO
Tax withholdingCommon Stock 695 $146.57 $101,866.15
Disclosure

SEC source: 0001225208-23-004522 · doc4.xml · nonDerivative · entry 2

Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,937.799

Read SEC document
April 01, 2023 Filed Apr 4, 2023 20:15 UTC
Stingi Richard JohnCorporate VP and CHRO
Exercise / conversionCommon Stock 1,360 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004522 · doc4.xml · nonDerivative · entry 1

Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,632.799

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2023 1,360 Restricted Stock Units vested and converted into an equal number of shares of common stock.

Read SEC document
April 01, 2023 Filed Apr 4, 2023 20:15 UTC
SCHIFELLITE ROBERTCorporate SVP
Tax withholdingCommon Stock 4,004 $146.57 $586,866.28
Disclosure

SEC source: 0001225208-23-004521 · doc4.xml · nonDerivative · entry 1

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,611.6729

Read SEC document
April 01, 2023 Filed Apr 4, 2023 20:15 UTC
KALENKA ROBERT FCorporate Vice President
Tax withholdingCommon Stock 1,170 $146.57 $171,486.90
Disclosure

SEC source: 0001225208-23-004517 · doc4.xml · nonDerivative · entry 1

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,632.4097

Read SEC document
April 01, 2023 Filed Apr 4, 2023 20:15 UTC Tax withholdingCommon Stock 4,950 $146.57 $725,521.50
Disclosure

SEC source: 0001225208-23-004519 · doc4.xml · nonDerivative · entry 1

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,859.528

Read SEC document
April 01, 2023 Filed Apr 4, 2023 20:15 UTC
DESCHUTTER DOUGLAS RICHARDCorporate Vice President
Tax withholdingCommon Stock 1,202 $146.57 $176,177.14
Disclosure

SEC source: 0001225208-23-004515 · doc4.xml · nonDerivative · entry 1

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Corporate Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,343.8948

Read SEC document
February 24, 2023 Filed Feb 27, 2023 20:15 UTC SaleCommon Stock 1,425 $141.06 $201,017.06
Disclosure

SEC source: 0001225208-23-002853 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · BOMAR II LLC

Disclosed balance after: 6,275

Read SEC document
February 15, 2023 Filed Feb 17, 2023 15:43 UTC
Matlin LauraVP, Deputy GC and CGO
GrantStock Option (Right to Buy) · Derivative 2,714 $0.00 Strike: $144.67 $0.00
Disclosure

SEC source: 0001225208-23-002237 · doc4.xml · derivative · entry 1

Matlin Laura · CIK 0001658944 · VP, Deputy GC and CGO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,714

Underlying: Common Stock · 2,714 shares

Expires 2033-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 20:43 UTC GrantStock Option (Right to Buy) · Derivative 135,366 $0.00 Strike: $144.67 $0.00
Disclosure

SEC source: 0001225208-23-002234 · doc4.xml · derivative · entry 1

Gokey Timothy C · CIK 0001296187 · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,366

Underlying: Common Stock · 135,366 shares

Expires 2033-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 15:43 UTC
DALY RICHARD JDirector · Executive Chairman
GrantStock Option (Right to Buy) · Derivative 5,714 $0.00 Strike: $144.67 $0.00
Disclosure

SEC source: 0001225208-23-002232 · doc4.xml · derivative · entry 1

DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,714

Underlying: Common Stock · 5,714 shares

Expires 2033-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 20:43 UTC
Reese EdmundCorporate VP and CFO
GrantStock Option (Right to Buy) · Derivative 30,716 $0.00 Strike: $144.67 $0.00
Disclosure

SEC source: 0001225208-23-002241 · doc4.xml · derivative · entry 1

Reese Edmund · CIK 0001833903 · Corporate VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,716

Underlying: Common Stock · 30,716 shares

Expires 2033-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 20:43 UTC
Stingi Richard JohnCorporate VP and CHRO
GrantStock Option (Right to Buy) · Derivative 8,571 $0.00 Strike: $144.67 $0.00
Disclosure

SEC source: 0001225208-23-002240 · doc4.xml · derivative · entry 1

Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,571

Underlying: Common Stock · 8,571 shares

Expires 2033-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 20:43 UTC
SCHIFELLITE ROBERTCorporate SVP
GrantStock Option (Right to Buy) · Derivative 26,073 $0.00 Strike: $144.67 $0.00
Disclosure

SEC source: 0001225208-23-002239 · doc4.xml · derivative · entry 1

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,073

Underlying: Common Stock · 26,073 shares

Expires 2033-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 20:43 UTC GrantStock Option (Right to Buy) · Derivative 37,502 $0.00 Strike: $144.67 $0.00
Disclosure

SEC source: 0001225208-23-002238 · doc4.xml · derivative · entry 1

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,502

Underlying: Common Stock · 37,502 shares

Expires 2033-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 20:43 UTC
KALENKA ROBERT FCorporate Vice President
GrantStock Option (Right to Buy) · Derivative 6,357 $0.00 Strike: $144.67 $0.00
Disclosure

SEC source: 0001225208-23-002236 · doc4.xml · derivative · entry 1

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,357

Underlying: Common Stock · 6,357 shares

Expires 2033-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 20:42 UTC
Carey Thomas PCorporate VP
GrantStock Option (Right to Buy) · Derivative 23,572 $0.00 Strike: $144.67 $0.00
Disclosure

SEC source: 0001225208-23-002231 · doc4.xml · derivative · entry 1

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,572

Underlying: Common Stock · 23,572 shares

Expires 2033-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.